At MIMS, our aim is to supply most current, practical and accessible knowledge to assist healthcare professionals practise effectively in the real world. Our editorial staff has a passion to ensure purity and accuracy in the medical knowledge we supply to you.
The MIMS medicine information that is utilised in the MIMS suite of products (with the exception of the decision support modules) is prepared by an editorial team of 40. Editorial staff, involved in reviewing, writing and abbreviating the medicine information or other technical information, are qualified in pharmacy, medicine or a related health science.
The team focus is on the quality and accuracy of all information and they follow a stringent editorial process to ensure data integrity as well as a consistent and easy to use range of products. All products are written and/or edited by the editorial team.
- Therapeutic Goods Administration (TGA): approved Product Information and Consumer Medicine Information supplied by manufacturers.
- Pharmaceutical Benefits Scheme (PBS): updates from Medicare Australia.
- World Health Organisation (WHO): Anatomical Therapeutic Chemical (ATC) classification.
- Australian Drug Evaluation Committee (ADEC): Pregnancy Classification.
- Advisory Committee on the Safety of Medicines (ACSOM) (replaced the Adverse Drug Reaction Committee (ADRAC in 2010): Adverse Event reports
- World Anti-Doping Agency (WADA): Sport Code for use in sports
- Other international regulatory bodies
- International research literature
MIMS Advisory Board and MIMS Alumni
MIMS Australia ensures input from external expert clinicians through the MIMS Advisory Board and MIMS Alumni. Board and alumni members come from a variety of disciplines and offer their expert knowledge and experience to the compilation of the MIMS content. The MIMS Chief Editor works closely with Board and Alumni members to ensure they remain abreast of issues and provide appropriate feedback.